Notably, prophylactic G-CSF did not significantly reduce the risk of later severe neutropenia or treatment with G-CSF (Fine-Gray, HR 0.74, 95% CI 0.43–1.25, P = 0.26). This evidence concerns the gene CSF3 and Decreased total neutrophil count.